SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950134-04-007487
Filing Date
2004-05-13
Accepted
2004-05-13 16:12:09
Documents
6
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f98957e10vq.htm 10-Q 191799
2 EXHIBIT 10.46 f98957exv10w46.txt EX-10.46 84732
3 EXHIBIT 10.47 f98957exv10w47.txt EX-10.47 56020
4 EXHIBIT 31.1 f98957exv31w1.txt EX-31.1 3535
5 EXHIBIT 31.2 f98957exv31w2.txt EX-31.2 3655
6 EXHIBIT 32.1 f98957exv32w1.txt EX-32.1 2667
  Complete submission text file 0000950134-04-007487.txt   344480
Mailing Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22570 | Film No.: 04803157
SIC: 2833 Medicinal Chemicals & Botanical Products